|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Case Report | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Volume 4, Number 4, August 2011, pages 168-173 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
A Case
of Hypereosinophilia-Associated Multiple Mass
Lesions
of Liver Showing Non-Granulomatous
Eosinophilic Hepatic Necrosis
Hiroko Ikedaa,
Kazuyoshi Katayanagib, Hiroshi Kurumayab, Kenichi
Haradac, Yasunori satoc, Motoko Sasakic,
Yasuni Nakanumac, d
aSection
of Diagnostic Pathology, Kanazawa University Hospital, Japan
Manuscript accepted for
publication July 19, 2011
Abstract
Hypereosinophilic
syndrome (HES) is defined by elevation more than 1.5×109/L
of presence of a peripheral blood count, evidence of organ involvement,
and exclusion of secondary eosinophilia such as allergic, vasculitis,
drugs, or parasite infection and also clonal eosinophilia. We present
the HES case with
hepatic involvement. The patient is 70-year-old male. He complained
fever and back pain. Blood examination showed marked peripheral
eosinophilia, elevation of transaminase and biliary enzymes. Multiple
irregular mass lesions of the liver were pointed out by CT and MRI. The
liver biopsy was done for differentiation from malignancy. In
parenchyma, hepatic necrotic lesion was observed accompanying severe
eosinophilic infiltration with Charcot-Leyden’s crystals. There was
granulomatous reaction. He was diagnosed as HES and got recovery due to
steroid therapy. From the review of HES article, the hepatic histology
is categorized into four types as below: 1) cholangitis type;
2) chronic active
hepatitis type; 3) vasculopathic type, 4) hepatic necrosis type. Our
case is classified in hepatic necrosis type. This type seems to be
important to distinguish malignant tumor and also visceral larva migrans
by liver biopsy. Keywords: Charcot-Leyden’s crystal; Chronic eosinophilic leukemia; Eosinophilia; Liver mass; Visceral larva migrans
Introduction Prominent eosinophilic infiltration of the liver is commonly seen in visceral larva migrans histologically presenting palisading granuloma [1, 2]. Occasional eosinophilic infiltration to some degree is known in drug-induced hypersensitivity as well as primary sclerosing cholangitis (PSC) [3], primary biliary cirrhosis (PBC) [4]. Hypereosinophilic syndrome (HES) is indispensable disease related to eosinophilic hepatic necrosis, although it is rare. Hypereosinophilic syndrome is thought to be a heterogeneous group of disorders characterized by peripheral eosinophilia and involvement of various organs. The diagnosis needs exclusion of other specific causes for eosinophilia such as infectious disease (parasitosis), autoimmune diseases (Churg-Strauss syndrome, Wegener granulomatosis), allergic inflammation to specific antigen, and neoplastic hematopoietic disorders [5]. Hepatic involvement of hypereosinophilic syndrome is uncommon, however, has been suggested to associate with the various type of liver injury. For example, cholangitis [6], chronic active hepatitis (CAH) [7], Budd-Chiari syndrome [8], and nodular regenerative hyperplasia (NRH) [9] has been reported in the patients of hypereosinophilic syndrome.
Herein, we present the
case of hypereosinophilia with hepatic eosinophilic necrosis in liver
histology and multiple liver mass lesions on radiological findings,
which was difficult to differentiate from malignancy.
Case Report
The steroid pulse
therapy was undergone after liver biopsy. The count of eosinophile in
peripheral blood fell down rapidly within normal range after steroid
therapy. The hepatic masses became gradually reduced and disappeared in
about half a year. He has been followed for 5 years and no
recurrence. Discussion Eosinophilia is generally categorized into clonal, secondary, and idiopathic types. Clonal eosinophilia is diagnosed by the presence of histologic, cytogenetic, or molecular evidence of an underlining myeloid malignancy. Actually, a lot of examination including the assessment of peripheral blood smear, bone marrow morphologic features, cytogenetic analysis, mutation analysis of specific gene, lymphocyte phenotyping, and T-cell receptor gene rearrangement are needed to rule out the clonal eosinophilia [11]. Our case is unlikely clonal type because of rapid improvement against steroid therapy, before vigorous examination. Secondary eosinophilia is caused by parasite infection, allergic, systemic vasculitis, drugs, and nonmyeloid malignancy. In our case, parasite infection, particularly visceral larva migrans, had to be differentiated because hepatic involvement with eosinophilia and multiple lesion on imaging is frequently observed. To our knowledge, the characteristic histological finding of parasitic infection is eosinophilic granuloma in almost cases, except one case of hydatid disease showing eosinophilic cholangitis [1, 2, 12-13]. It seemed that the possibility of visceral larva migrans could be denied because the granulomatous reaction was not found at all in liver biopsy, and antihelminthic treatment was not needed in our patient. Specific factor determining cause of eosinophilia didn’t detected over five years, although it seems to be difficult complete exclusion of secondary eosinophilia.
HES is a
subcategory of idiopathic type, and defined by the presence of a
peripheral blood eosinophil count of 1.5
×
109/L or greater for at least 6 months, exclusion of
both clonal and secondary eosinophilia, evidence of organ involvement,
like as Chusid et al. proposed in 1975 [11,
14]. This
case didn’t fill strictly above criteria, however, he was good responder
of corticosteroid therapy, which is the first-line therapy for HES [5].
A shorter duration by the proper therapy has been allowed for diagnosis
for HES [11],
therefore, this case likely to be HES.
We presented in this
article the case of hepatic eosinophilic necrosis showed liver mass
lesions and reviewed the liver histology of HES. In conclusion, the
histology is categorized four types: cholangitis type, CAH type,
vasculopathic type, and hepatic necrosis type. PSC, PBC, AIH, neoplastic
eosinophilia, parasitic infection, malignancy, and drug can be
differential disease in each type. It is important that HES is one of
the mass forming disease in liver, and liver biopsy is useful to exclude
differential disease for steroid therapy. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| References | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1. |
Kaplan KJ, Goodman ZD,
Ishak KG. Eosinophilic granuloma of the liver: a characteristic lesion
with relationship to visceral larva migrans.
Am J Surg Pathol. 2001;25(10):1316-1321. [Medline] |
| 2. |
Leone N, Baronio M,
Todros L, David E, Brunello F, Artioli S, Rizzetto M. Hepatic
involvement in larva migrans of Toxocara canis: report of a case with
pathological and radiological findings.
Dig Liver Dis. 2006;38(7):511-514. [Medline] |
| 3. |
Watanabe H, Ohira H,
Kuroda M, Takagi T, Ishikawa H, Nishimaki T, Kasukawa R, et al. Primary
sclerosing cholangitis with marked eosinophilic infiltration in the liver.
J Gastroenterol. 1995;30(4):524-528. [Medline] |
| 4. |
Hiramatsu
K, Aoyama H, Zen Y, Aishima S, Kitagawa S, Nakanuma Y. Proposal of a new
staging and grading system of the liver for primary biliary cirrhosis.
Histopathology. 2006;49(5):466-478. [Medline] |
| 5. |
Wilkins HJ, Crane MM,
Copeland K, Williams WV. Hypereosinophilic syndrome: an update.
Am J Hematol. 2005;80(2):148-157. [Medline] |
| 6. |
Grauer L, Padilla VM,
3rd, Bouza L, Barkin JS. Eosinophilic sclerosing cholangitis associated
with hypereosinophilic syndrome.
Am J Gastroenterol. 1993;88(10):1764-1769. [Medline] |
| 7. |
Foong A,
Scholes JV, Gleich GJ, Kephart GM, Holt PR. Eosinophil-induced chronic
active hepatitis in the idiopathic hypereosinophilic syndrome.
Hepatology. 1991;13(6):1090-1094. [Medline] |
| 8. |
Inoue A, Michitaka K,
Shigematsu S, Konishi I, Hirooka M, Hiasa Y, Matsui H, et al.
Budd-Chiari syndrome associated with hypereosinophilic syndrome; a case
report. Intern Med. 2007;46(14):1095-1100. [Medline] |
| 9. |
Baker BL, Axiotis C,
Hurwitz ES, Leavitt R, Di Bisceglie AM. Nodular regenerative hyperplasia
of the liver in idiopathic hypereosinophilic syndrome.
J Clin Gastroenterol.
1991;13(4):452-456. [Medline] |
| 10. |
Woschnagg C, Rubin J,
Venge P. Eosinophil cationic protein (ECP) is processed during secretion.
J Immunol. 2009;183(6):3949-3954. [Medline] |
| 11. |
Tefferi A, Gotlib J,
Pardanani A. Hypereosinophilic syndrome and clonal eosinophilia:
point-of-care diagnostic algorithm and treatment update.
Mayo Clin Proc. 2010;85(2):158-164. [Medline] |
| 12. |
Musso C,
Castelo JS, Tsanaclis AM, Pereira FE. Prevalence of Toxocara-induced
liver granulomas, detected by immunohistochemistry, in a series of
autopsies at a Children's Reference Hospital in Vitoria, ES, Brazil.
Virchows
Arch. 2007;450(4):411-417. [Medline] |
| 13. |
Raptou G, Pliakos I,
Hytiroglou P, Papavramidis S, Karkavelas G. Severe eosinophilic
cholangitis with parenchymal destruction of the left hepatic lobe due to
hydatid disease. Pathol Int.
2009;59(6):395-398. [Medline] |
| 14. |
Chusid
MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis
of fourteen cases with review of the literature. Medicine.
1975;54(1):1-27. [Medline] |
| 15. |
Fauci AS, Harley JB,
Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH conference. The
idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and
therapeutic considerations.
Ann Intern Med. 1982;97(1):78-92. [Medline] |
| 16. |
Scheurlen M, Mork H,
Weber P. Hypereosinophilic syndrome resembling chronic inflammatory
bowel disease with primary sclerosing cholangitis.
J Clin Gastroenterol. 1992;14(1):59-63. [Medline] |
| 17. |
Dillon JF, Finlayson ND.
Idiopathic hypereosinophilic syndrome presenting as intrahepatic
cholestatic jaundice. Am J
Gastroenterol. 1994;89(8):1254-1255. [Medline] |
| 18. |
Schoonbroodt D, Horsmans
Y, Laka A, Geubel AP, Hoang P. Eosinophilic gastroenteritis presenting
with colitis and cholangitis.
Dig Dis Sci. 1995;40(2):308-314. [Medline] |
| 19. |
Sussman DA, Bejarano PA,
Regev A. Eosinophilic cholangiopathy with concurrent eosinophilic
colitis in a patient with idiopathic hypereosinophilic syndrome.
Eur J Gastroenterol Hepatol. 2008;20(6):574-577. [Medline] |
| 20. |
Croffy B, Kopelman R,
Kaplan M. Hypereosinophilic syndrome. Association with chronic active
hepatitis. Dig Dis Sci. 1988;33(2):233-239. [Medline] |
| 21. |
Ung KA, Remotti H,
Olsson R. Eosinophilic hepatic necrosis in hypereosinophilic syndrome.
J Clin Gastroenterol. 2000;31(4):323-327.
[Medline] |
| 22. |
Lai M, Afdhal N,
Challies T. Liver masses and eosinophilia.
Liver Int. 2008;28(1):150. [Medline] |
| 23. | Brain BJ, Gilliland DG, Vardiman JW, Horny HP. Chronic eosinophilic leulaemia, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thile J, Vardiman JW (Eds.): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC): Lyon 2008 |
| 24. |
Kim GB, Kwon JH, Kang
DS. Hypereosinophilic syndrome: imaging findings in patients with
hepatic involvement. AJR Am J
Roentgenol. 1993;161(3):577-580. [Medline] |
| 25. |
Reyes M, Abraham C,
Abedi M, Carucci LR, Schwartz LB. Hypereosinophilic syndrome with
hepatobiliary masses and obstructive jaundice.
Ann Allergy Asthma Immunol. 2005;94(1):25-28. [Medline] |
| 26. |
Sun JS, Kim JK, Won JH, Lee KM, Cheong JY, Kim YB. MR findings in
eosinophilic infiltration of the liver.
J Comput Assist Tomogr. 2005;29(2):191-194.
[Medline] |
Digital Object Identifier (DOI):10.4021/gr336e
About
DOI and
CrossRef
Gastroenterology Research is a member of CrossRef.




